BioGaia AB (publ) (LON: 0GTN)
London
· Delayed Price · Currency is GBP · Price in SEK
116.50
+0.60 (0.52%)
At close: Jan 21, 2025
BioGaia AB Company Description
BioGaia AB (publ), a healthcare company, provides probiotic products worldwide.
The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula.
The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee’s dairy product.
The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels.
BioGaia AB (publ) was incorrporated in 1990 and is based in Stockholm, Sweden.
BioGaia AB (publ)
Country | Sweden |
Founded | 1990 |
Industry | Pharmaceutical Preparations |
Employees | 210 |
CEO | Theresa Agnew |
Contact Details
Address: Kungsbroplan 3 Stockholm, 112 27 Sweden | |
Phone | 46 8 55 52 93 00 |
Website | biogaia.com |
Stock Details
Ticker Symbol | 0GTN |
Exchange | London Stock Exchange |
Share Class | Class B Shares |
Fiscal Year | January - December |
Reporting Currency | SEK |
ISIN Number | SE0017769995 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Theresa P. Agnew | Chief Executive Officer and President |
Peter Rothschild M.Sc. Econ., MBA | Founder and Chairman |
Alexander Kotsinas M.Sc. (Eng.). | Executive Vice President and Chief Financial Officer |
Ludvig Milesson | Chief Operating Officer |
Gianfranco Grompone | Chief Scientific Officer and Vice President of Research and Development |
Caroline Mofors | Chief Legal Officer |
Linda Hagglund | Vice President of Marketing |
Angelika Kjelldorff | Chief Human Resources Officer |
Sebastian Heimfors | Vice President and Chief Commercial Officer |
Jonathan Gromark | Sustainability Manager |